These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 18789789)

  • 21. Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity.
    Mnie-Filali O; El Mansari M; Espana A; Sànchez C; Haddjeri N
    Neurosci Lett; 2006 Feb; 395(1):23-7. PubMed ID: 16330146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
    Sanchez C; Reines EH; Montgomery SA
    Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study.
    Finnema SJ; Halldin C; Bang-Andersen B; Bundgaard C; Farde L
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4159-67. PubMed ID: 25980484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane.
    Nichols AL; Blumenfeld Z; Luebbert L; Knox HJ; Muthusamy AK; Marvin JS; Kim CH; Grant SN; Walton DP; Cohen BN; Hammar R; Looger L; Artursson P; Dougherty DA; Lester HA
    J Neurosci; 2023 Mar; 43(13):2222-2241. PubMed ID: 36868853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporter.
    Larsen MA; Plenge P; Andersen J; Eildal JN; Kristensen AS; Bøgesø KP; Gether U; Strømgaard K; Bang-Andersen B; Loland CJ
    Br J Pharmacol; 2016 Mar; 173(5):925-36. PubMed ID: 26699847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram.
    Kasper S; Sacher J; Klein N; Mossaheb N; Attarbaschi-Steiner T; Lanzenberger R; Spindelegger C; Asenbaum S; Holik A; Dudczak R
    Int Clin Psychopharmacol; 2009 May; 24(3):119-25. PubMed ID: 19367152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels.
    Bundgaard C; Larsen F; Jørgensen M; Gabrielsson J
    Eur J Pharm Sci; 2006 Dec; 29(5):394-404. PubMed ID: 17014998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. R-citalopram prevents the neuronal adaptive changes induced by escitalopram.
    Mnie-Filali O; Faure C; Mansari ME; Lambás-Señas L; Bérod A; Zimmer L; Sánchez C; Haddjeri N
    Neuroreport; 2007 Oct; 18(15):1553-6. PubMed ID: 17885600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of a high-affinity allosteric inhibitor of the serotonin transporter.
    Plenge P; Abramyan AM; Sørensen G; Mørk A; Weikop P; Gether U; Bang-Andersen B; Shi L; Loland CJ
    Nat Commun; 2020 Mar; 11(1):1491. PubMed ID: 32198394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
    Owens MJ; Knight DL; Nemeroff CB
    Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Escitalopram versus citalopram: the surprising role of the R-enantiomer.
    Sánchez C; Bøgesø KP; Ebert B; Reines EH; Braestrup C
    Psychopharmacology (Berl); 2004 Jul; 174(2):163-76. PubMed ID: 15160261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model.
    Sánchez C; Gruca P; Papp M
    Behav Pharmacol; 2003 Sep; 14(5-6):465-70. PubMed ID: 14501259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. R-citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter.
    Stórustovu Sí; Sánchez C; Pörzgen P; Brennum LT; Larsen AK; Pulis M; Ebert B
    Br J Pharmacol; 2004 May; 142(1):172-80. PubMed ID: 15037515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of sustained serotonin reuptake inhibition on the firing of dopamine neurons in the rat ventral tegmental area.
    Dremencov E; El Mansari M; Blier P
    J Psychiatry Neurosci; 2009 May; 34(3):223-9. PubMed ID: 19448853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats.
    Mørk A; Kreilgaard M; Sánchez C
    Neuropharmacology; 2003 Aug; 45(2):167-73. PubMed ID: 12842122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ontogeny of SERT Expression and Antidepressant-like Response to Escitalopram in Wild-Type and SERT Mutant Mice.
    Mitchell NC; Gould GG; Koek W; Daws LC
    J Pharmacol Exp Ther; 2016 Aug; 358(2):271-81. PubMed ID: 27288483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions.
    Plenge P; Wiborg O
    Neurosci Lett; 2005 Aug; 383(3):203-8. PubMed ID: 15955412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [
    Kim E; Howes OD; Kim BH; Chon MW; Seo S; Turkheimer FE; Lee JS; Lee YS; Kwon JS
    Clin Pharmacokinet; 2017 Apr; 56(4):371-381. PubMed ID: 27557550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram.
    Sánchez C; Kreilgaard M
    Pharmacol Biochem Behav; 2004 Feb; 77(2):391-8. PubMed ID: 14751469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.